Ginkgo Bioworks DNA Current ratio

Current ratio at other companies

Thermo Fisher ScientificTMO

1.6×-0.4×

Charles River LaboratoriesCRL

1.3×0.0×

AbCellera Biologics Inc.ABCL

12.8×+1.7×

eXoZymes, Inc.EXOZ

1.3×-5.2×

TEC

Bio-TechneTECH

4.5×+0.8×

RevvityRVTY

1.8×-1.5×

FAQ

What is Ginkgo Bioworks's current ratio?

Ginkgo Bioworks (DNA) reported current ratio of 4.6× in Q2 2026.

How has Ginkgo Bioworks's current ratio changed year-over-year?

Ginkgo Bioworks's current ratio decreased by 15.5% year-over-year, from 5.4× to 4.6×.

What is the long-term trend for Ginkgo Bioworks's current ratio?

Over 5 years (2020 to 2025), Ginkgo Bioworks's current ratio has grown at a -3.3% compound annual growth rate (CAGR), from 5.8× to 4.9×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.